東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ null ]

切換: 標籤 | MARC模式 | ISBD

Heterogeneities in Alzheimer's Disea...

Jonson, Caroline,

FindBook

Google Book

Amazon

博客來

Heterogeneities in Alzheimer's Disease and Related Dementias: Elucidating the Genetic and Transcriptomic Underpinnings /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Heterogeneities in Alzheimer's Disease and Related Dementias: Elucidating the Genetic and Transcriptomic Underpinnings // Caroline Jonson.
作者:	Jonson, Caroline,
面頁冊數:	1 electronic resource (230 pages)
附註:	Source: Dissertations Abstracts International, Volume: 85-09, Section: B.
Contained By:	Dissertations Abstracts International85-09B.
標題:	Genetics. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30991867
ISBN:	9798381971644

Heterogeneities in Alzheimer's Disease and Related Dementias: Elucidating the Genetic and Transcriptomic Underpinnings /
Jonson, Caroline,

Heterogeneities in Alzheimer's Disease and Related Dementias: Elucidating the Genetic and Transcriptomic Underpinnings /Caroline Jonson. - 1 electronic resource (230 pages)

Source: Dissertations Abstracts International, Volume: 85-09, Section: B.

Despite the tremendous burden of Alzheimer's disease and related dementias (ADRD on patients, their families, and the public health system, there are still no effective treatments for the disease. Seeking a better understanding of important disease-subgroup-specific associations in a highly heterogeneous patient population, like those diagnosed with ADRD, can help facilitate the development of new therapeutics by enhancing clinical trial design. This thesis focuses on elucidating the genetic and transcriptomic underpinnings of the heterogeneities in ADRD and where these subgroups mechanistically converge.Chapter 1 focuses on features driving sex differences in AD progression to help reveal what protects some individuals and what makes others more vulnerable, ultimately informing the development of personalized therapeutics that benefit both sexes.Chapter 2 presents a meta-analysis of Alzheimer's disease genetics across multiple ancestries and highlights the current lack of diversity in neurodegenerative disease genetic research, suggesting a need for more inclusive studies.Chapter 3 links peripheral immune changes to familial tauopathy and early-onset Alzheimer's, showing altered monocytes in tauopathies and increased interferon-responsive T cells in EOAD. This chapter highlights the importance of the immune system in ADRD.

English

ISBN: 9798381971644Subjects--Topical Terms:

530508
Genetics.
Subjects--Index Terms:

Ancestral differences

Heterogeneities in Alzheimer's Disease and Related Dementias: Elucidating the Genetic and Transcriptomic Underpinnings /
LDR:02912nmm a22004693i 4500 001 2437480
005 20251124054752.5
006 m o d
007 cr|nu||||||||
008 261011s2024 miu||||||m |||||||eng d
020 $a 9798381971644
035 $a (MiAaPQD)AAI30991867
035 $a AAI30991867
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Jonson, Caroline, $e author. $0 (orcid)0000-0001-7049-6281 $3 3828467
245 1 0 $a Heterogeneities in Alzheimer's Disease and Related Dementias: Elucidating the Genetic and Transcriptomic Underpinnings / $c Caroline Jonson.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (230 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-09, Section: B.
500 $a Advisors: Yokoyama, Jennifer Committee members: Nalls, Mike; Rabinovici, Gil.
502 $b Ph.D. $c University of California, San Francisco $d 2024.
520 $a Despite the tremendous burden of Alzheimer's disease and related dementias (ADRD on patients, their families, and the public health system, there are still no effective treatments for the disease. Seeking a better understanding of important disease-subgroup-specific associations in a highly heterogeneous patient population, like those diagnosed with ADRD, can help facilitate the development of new therapeutics by enhancing clinical trial design. This thesis focuses on elucidating the genetic and transcriptomic underpinnings of the heterogeneities in ADRD and where these subgroups mechanistically converge.Chapter 1 focuses on features driving sex differences in AD progression to help reveal what protects some individuals and what makes others more vulnerable, ultimately informing the development of personalized therapeutics that benefit both sexes.Chapter 2 presents a meta-analysis of Alzheimer's disease genetics across multiple ancestries and highlights the current lack of diversity in neurodegenerative disease genetic research, suggesting a need for more inclusive studies.Chapter 3 links peripheral immune changes to familial tauopathy and early-onset Alzheimer's, showing altered monocytes in tauopathies and increased interferon-responsive T cells in EOAD. This chapter highlights the importance of the immune system in ADRD.
546 $a English
590 $a School code: 0034
650 4 $a Genetics. $3 530508
650 4 $a Neurosciences. $3 588700
650 4 $a Pharmacology. $3 634543
650 4 $a Molecular biology. $3 517296
650 4 $a Immunology. $3 611031
653 $a Ancestral differences
653 $a Dementias
653 $a Genome wide association study
653 $a Genomics
653 $a Sex differences
653 $a Transcriptomics
690 $a 0369
690 $a 0317
690 $a 0982
690 $a 0419
690 $a 0307
710 2 $a University of California, San Francisco. $b Pharmaceutical Sciences and Pharmacogenomics. $e degree granting institution. $3 3828468
720 1 $a Yokoyama, Jennifer $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 85-09B.
790 $a 0034
791 $a Ph.D.
792 $a 2024
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30991867